What is it about?
This article describes OCA genes. These genes include non-syndromic OCA genes and syndromic OCA genes. Eight genes determine the non-syndromic OCA. These comprise TYR, OCA2, MC1R, TYRP1, SLC45A2, OCA5, SLC24A5, and LRMDA. The syndromic OCA genes include CH1S, HPS1, HPS2, HPS3, HPS4, HPS5, HPS6, DTNBP1, BLOC1S3, and BLOC1S6.
Featured Image
Why is it important?
In this article, the author describes progress in the study of OCA. The author focuses in the genetic aspects. These include gene in the disorders, and gene therapy for OCA.
Perspectives
People with OCA disorders can dream to teach their OCA disorders. It has never happened before. Even people who want to be OCA4 for example, can do so. That is the technology of gene therapy in the future.
Martin Nelwan
Nelwan Institution for Human Resource Development
Read the Original
This page is a summary of: Treat Oculocutaneous Albinism with Gene Therapy, Journal of Advances in Biology & Biotechnology, January 2018, Sciencedomain International,
DOI: 10.9734/jabb/2017/38504.
You can read the full text:
Contributors
The following have contributed to this page
